Search fresh public links, source activity, and ready-to-use post angles for A2B Trial.
Fresh curated links around A2B Trial are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
There is some news from the MS Society https://www.mssociety.org.uk/research/latest-research/latest-research-news-and-blogs/alpha-lipoic-acid-moves-next-stage-octopus-trial Octopus...
Remission results nearly double published ven/aza outcomes in patients with historically limited treatment success
HONG KONG, Oct. 10, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that the first patient has been dosed in a Phase III clinical study (COMPASSION-...
Does primary sedation with dexmedetomidine or clonidine reduce the time to successful extubation in mechanically ventilated critically ill patients compared to propofol-based sedat...
TLC BioSciences Corp. today announced positive topline results from its pivotal Phase 3 trial of TLC590.
An experimental oral drug called remibrutinib outperformed the approved therapy Aubagio (teriflunomide) in reducing disease flare rates in two large, late-stage clinical trials inv...
Is there advantage of stem therapy over standard immunosuppressive treatment? Let’s look at the data and the answer is probably yes….but then we get the punchline “Well-designed ra...
The answer to this is unlikely to occur from a proper clinical trial done by pharma as it would be dangerous if there is a difference and one seems better than the other. MSBase is...
A spokesperson confirmed that a “limited number” of liver-related safety events, including a patient death, were observed in testing of Bristol Myers’ admilparant — though it’s unc...
- Expected to enroll approximately 4,600 participants with obesity or overweight across two pivotal trials (AURORA-1 and AURORA-2) in the U.S., Europe, and Canada.
Company Making Critical Progress in Scalable Manufacturing and Preparing the Lead Trispecific Candidate for Future Human TestingTrispecifics Combine Three Complementary Cancer-Figh...
The better-than-expected results could make Epkinly the new “undisputed” treatment standard in newly diagnosed DLBCL, according to one analyst.
In 2010, the CRASH-2 trial was published in the Lancet.[1] The authors randomized 20,211 trauma patients with, or at risk of, significant hemorrhage within 8 hours of injury to eit...
One year of TOWARD Health's physician-led metabolic continuous-care intervention reduced estimated 10-year ASCVD risk by 29% and total cardiovascular risk by 28% BLAUVELT, N.Y., Oc...
The drugmaker is leaning on a better side effect profile compared to drugs from J&J, Pfizer and Regeneron as it pushes etentamig toward FDA submission.
Only the lower of two tested doses of the idiopathic pulmonary fibrosis drug admilparant met the trial’s main objective, adding to analyst questions about the therapy’s prospects.
New criteria fully approved at nine of eleven active sites expected to significantly accelerate enrollment pace.
By: Jessica Nye, Ph From: oncologynurseadvisor.com n a safety review of the HER2CLIMB trial, grade 3 or higher AEs occurred in 55.2% of patients receiving TTC compared with 48.7% r...
Tiziana Life Sciences has signed a deal with strategic partners to support a clinical trial designed to test its experimental nasal therapy foralumab in people with hard-to-treat r...
Will Lorecivivintâ„¢ transform hip, knee, extremity and spine OA treatment?
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.